Search

everythinglearnresearchcommunity

for

Search:↓

Dogs could be good models for studying human hair growth and hair loss.

Different types of dog hair loss are linked to problems starting the hair growth phase and early hair cycle ending.

Immune cells affect hair growth and could lead to new hair loss treatments.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.

EPR spectroscopy showed that spontaneous hair growth results in thicker skin and less pigmented hair than depilation-induced growth.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

Hair characteristics might be early signs of Type 2 Diabetes and could help with early prevention.

Understanding hair biology is key to developing better treatments for hair and scalp issues.

Ketoconazole may help regrow hair and increase follicle size, but more research needed.

The study suggests that a new protease inhibitor can make hair harder to pull out, potentially reducing hair loss.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

CTE and FPHL are different hair loss types with unique causes.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Algal oligosaccharides help prevent hair loss and promote hair growth.

Dermoscopy shows that diffuse alopecia areata progresses through specific hair growth stages.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Hair loss from telogen effluvium can cause mental health issues and lower life quality, needing both medical and emotional support.

Vitamin A deficiency changes cattle hair structure, while pregnancy may improve it, suggesting hair can indicate cattle health.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Using 448-kHz Capacitive-Resistive Electrothermal Therapy can help increase hair density and prevent hair loss in women.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Hair loss caused by genetics and hormones; more research needed for treatments.

The study suggests that a specific gene variation and higher gene activity are linked to increased baldness in Egyptian men.